sesamin has been researched along with Sepsis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| AbouZid, SF; Ahmed, OM; Ali, TM; Almoiliqy, M; An, S; Anggraeni, AT; Bailón-García, E; Bueno-López, A; Buyze, J; Chen, DQ; Chen, X; Davó-Quiñonero, A; De Weggheleire, A; Ding, Z; El-Kalaawy, AM; Elesawy, BH; Francque, S; Gao, F; Guo, Y; Juan-Juan, J; Li, S; Li, Y; Lin, Y; Liu, X; Liu, Z; Lozano-Castelló, D; Lu, X; Lynen, L; Meng, Q; Peng, J; Ran, Y; Razali, MH; Rodríguez, SL; Shen, MJ; Soedarsono, S; Soeprijanto, B; Su, W; Sun, P; Tang, AL; Thai, S; Tian, G; Topîrceanu, A; van Griensven, J; Wang, H; Wang, Y; Wen, J; Xi, J; Xiong, MC; Yang, S; Yang, X; Yassin, NYS; Ye, L; Yusoff, M; Zhang, GQ; Zhang, Y | 1 |
| Gao, M; Li, ZL; Liu, JJ; Xiao, XF; Yang, BC; Yang, MS | 1 |
| Bae, JS; Han, CK; Ku, SK; Lee, W; Yoo, H | 1 |
3 other study(ies) available for sesamin and Sepsis
| Article | Year |
|---|---|
Topics: Acute Lung Injury; Adherens Junctions; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antigens, CD; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; beta Catenin; Brain Ischemia; Cadherins; Carcinogenesis; Catalysis; Cell Line; Cells, Cultured; Curcuma; Curcumin; Dioxoles; Disease Models, Animal; Endothelial Cells; Epithelial Cells; Heme Oxygenase (Decyclizing); Humans; Inflammasomes; Intestinal Diseases; Intestinal Mucosa; Ischemic Stroke; Kidney Neoplasms; Lignans; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NAD(P)H Dehydrogenase (Quinone); Nanostructures; NF-E2-Related Factor 2; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Pneumonia; PPAR gamma; Proto-Oncogene Proteins c-akt; Pyroptosis; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reperfusion Injury; Respiratory Distress Syndrome; Sepsis; Sesamum; Signal Transduction; Silybin; Silybum marianum; Silymarin; Sirtuin 3; Titanium; Transfection; Treatment Outcome; White Matter | 2021 |
Sesamin attenuates intestinal injury in sepsis via the HMGB1/TLR4/IL-33 signalling pathway.
Topics: Animals; Bacteria; Cell Line; Cytokines; Dioxoles; Disease Models, Animal; Epithelial Cells; HMGB1 Protein; Humans; Inflammation; Interleukin-33; Intestinal Mucosa; Lignans; Male; Mice; Mice, Inbred BALB C; Occludin; Sepsis; Signal Transduction; Toll-Like Receptor 4; Zonula Occludens-1 Protein | 2020 |
Inhibitory effects of epi-sesamin on endothelial protein C receptor shedding in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Cells, Cultured; Dioxoles; Endothelial Protein C Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; Lignans; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Receptors, Cell Surface; Sepsis; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2013 |